Systemic hormone therapy during menopause may up risk for depression

Glass laboratory flasks on light table

Systemically administered hormone therapy (HT) during menopause is associated with a higher risk for depression, according to a study published online Nov. 1 in JAMA Network Open.

The best laptop deals as of Nov. 4: Save $600 on a Razer Blade 14 gaming laptop and more

Previous article

The early bird may just get the worm

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in Innovations